CD8A and cancer: By transferring bacteria from healthy individuals into cancer patients, the immune system may shift to a more tumor-suppressing phenotype directly enhancing the cytotoxic effects of CD8+ T cells or activating mechanisms such as STING signaling or NK cell activation (102, 105–107).